Paired facial treatment with 755nm picosecond laser with diffractive lens array and 1060nm laser lipolysis of the submentum: An open‐label prospective trial. (27th August 2021) - Wang, Jordan V.
Abstract: Background: Performing multiple cosmetic treatments in a single session to target different aspects of facial rejuvenation is an effective regimen. Picosecond lasers with a fractionated handpiece can target fine lines, which can supplement submental fat reduction procedures. However, limited data exist on the safety and efficacy of single‐session treatment strategies. Aims: To assess the safety and utility of paired facial treatment with 755 nm picosecond laser with diffractive lens array (DLA) and 1060 nm laser lipolysis of the submentum. Patients/Methods: A prospective clinical study investigated the utility of paired facial treatment with 755 nm picosecond laser with DLA and 1060 nm diode laser lipolysis of the submentum. Subjects received treatments during the same session. Subjects were enrolled to receive up to 3 picosecond laser and 2 lipolysis treatments at 2‐8‐week intervals. Results: Eleven subjects completed the study. Mean age was 52.1 years, and 81.8% were female. Fitzpatrick skin types II‐VI were represented. For investigator global aesthetics improvement scores (GAIS), 63.6%, 81.8%, and 85.7% had improvement from baseline at 30‐, 90‐, and 180‐day follow‐up, respectively. At 180‐day follow‐up, 100% maintained improvement from 90‐day follow‐up. At 90‐day follow‐up, calculations for neck laxity showed a significant improvement of 11.7% from baseline ( p < 0.001) with a mean amount of lift of 42.7 mm 2, which was above the predetermined threshold (20 mm 2 ). No serious or unexpected treatment effects were observed. Conclusion: Paired facial treatment with 755 nm picosecond laser with DLA and 1060 nm laser lipolysis of the submentum improved clinical aesthetic outcomes. This treatment regimen was demonstrated to be safe, well‐tolerated, and well‐liked by subjects.